(Q48474897)

11 February 2018

title

Surgeon perspectives about local therapy for breast carcinoma (English)

1 reference

11 February 2018

10

Monica Morrow

1 reference

11 February 2018

7

Dennis Deapen

1 reference

11 February 2018

Angela Fagerlin

4

object named as

Angela Fagerlin

1 reference

11 February 2018

Steven J Katz

1

object named as

Steven J Katz

1 reference

11 February 2018

author name string

Paula M Lantz

2

1 reference

11 February 2018

Nancy K Janz

3

1 reference

11 February 2018

Kendra Schwartz

5

1 reference

11 February 2018

Lihua Liu

6

1 reference

11 February 2018

Barbara Salem

8

1 reference

11 February 2018

Indu Lakhani

9

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 November 2005

1 reference

11 February 2018

number of pages

8

1 reference

inferred from page(s)

published in

Cancer

1 reference

11 February 2018

volume

104

1 reference

11 February 2018

issue

9

1 reference

11 February 2018

page(s)

1854-1861

1 reference

11 February 2018

Ductal carcinoma in situ of the breast

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

Geographic variation in the treatment of localized breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Geographic variation in the use of breast-conserving treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Incidence of and treatment for ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Surgeon perspectives on surgical options for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Unwarranted variations in healthcare delivery: implications for academic medical centres

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Local and national trends over a decade in the surgical treatment of ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Trends in the treatment of ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Compliance with breast-conservation standards for patients with early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

How breast cancer treatment decisions are made by women in North Dakota

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Clinicopathologic factors and patient perceptions associated with surgical breast-conserving treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Women's use of resources in decision-making for early-stage breast cancer: results of a community-based survey

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Factors influencing a woman's choice to undergo breast-conserving surgery versus modified radical mastectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Predictors of patients' choices for breast-conserving therapy or mastectomy: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Practice patterns in breast cancer surgery: Canadian perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Measuring and predicting surgeons' practice styles for breast cancer treatment in older women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Patient involvement in surgery treatment decisions for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Determinants of receiving breast-conserving surgery. The Surveillance, Epidemiology, and End Results Program, 1983-1986.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Use of breast-conserving surgery for treatment of stage I and stage II breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Medical contraindications are not a major factor in the underutilization of breast conserving therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21396

7 January 2021

Identifiers

DOI

10.1002/CNCR.21396

1 reference

11 February 2018

1 reference

11 February 2018